Clinical trial
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With…
NCT00447954 · Neurotech Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00447954 |
|---|---|
| Title | A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration |
| Official title | A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration |
| Lead sponsor | Neurotech Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage |
| Intervention type | Combination Product, Other |
| Interventions | High Dose NT-501 implant, Low Dose NT-501 implant, Sham |
| Enrollment | 53 |
| Start date | Jan 5, 2007 |
| Primary completion | May 11, 2009 |
| Completion | May 11, 2009 |
| First posted | Mar 15, 2007 |
| Last update posted | Mar 28, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: